IRIS
SCHWARTZ, PETER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.043
EU - Europa 8.851
AS - Asia 6.611
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 13
SA - Sud America 7
Totale 27.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.924
CN - Cina 6.548
IE - Irlanda 2.589
UA - Ucraina 2.005
DE - Germania 1.153
FI - Finlandia 919
SE - Svezia 867
IT - Italia 634
GB - Regno Unito 399
FR - Francia 145
CA - Canada 115
RU - Federazione Russa 43
BE - Belgio 39
IN - India 31
MU - Mauritius 31
NL - Olanda 29
EU - Europa 17
IR - Iran 17
ES - Italia 13
AU - Australia 10
CL - Cile 4
HU - Ungheria 4
MX - Messico 4
MY - Malesia 3
NZ - Nuova Zelanda 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
DK - Danimarca 2
GR - Grecia 2
IQ - Iraq 2
JP - Giappone 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CO - Colombia 1
ET - Etiopia 1
HK - Hong Kong 1
ID - Indonesia 1
LU - Lussemburgo 1
LV - Lettonia 1
PK - Pakistan 1
SA - Arabia Saudita 1
TR - Turchia 1
VN - Vietnam 1
Totale 27.575
Salva come PNG Salva come JPEG
Città #
Chandler 2.644
Jacksonville 2.587
Dublin 2.585
Nanjing 2.096
Ashburn 851
Nanchang 850
Princeton 640
Lawrence 603
Shenyang 593
Hebei 571
Wilmington 559
Changsha 558
Jiaxing 510
Medford 408
Tianjin 324
Hangzhou 310
Beijing 285
Boardman 268
Helsinki 209
Ann Arbor 195
Woodbridge 148
Milan 129
Norwalk 112
Verona 111
Shanghai 65
Fairfield 61
Toronto 59
Kunming 54
Houston 53
New York 53
Pavia 53
Mcallen 52
Seattle 51
Des Moines 47
Washington 45
Falls Church 42
Munich 39
Montréal 37
Ningbo 35
Brussels 34
Zhengzhou 34
Jinan 33
Dearborn 23
Fuzhou 22
Lanzhou 19
Pune 19
Orange 18
Guangzhou 17
Rome 17
San Genesio Ed Uniti 17
Tappahannock 17
Taizhou 16
Changchun 15
Berlin 14
Los Angeles 14
Auburn Hills 13
Borås 13
Chieti 10
Pescara 8
Redwood City 8
Rochester 8
Catanzaro 7
Madrid 7
San Francisco 7
Mountain View 6
Bari 5
Falkenstein 5
Monmouth Junction 5
Napoli 5
Padova 5
Palermo 5
Saint Petersburg 5
Saint-herblain 5
Tübingen 5
Walnut 5
Zola Predosa 5
Bastia umbra 4
Florence 4
Frankfurt am Main 4
Hefei 4
Jinhua 4
Kingston 4
Legnaro 4
Leuven 4
Melbourne 4
Mexico City 4
Rockville 4
Szeged 4
Van Nuys 4
Villalvernia 4
Weinan 4
Zanjan 4
Ardabil 3
Ferrara 3
Ferrol 3
Haikou 3
Kansas City 3
Kemerovo 3
Las Vegas 3
London 3
Totale 19.451
Salva come PNG Salva come JPEG
Nome #
Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. 218
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 213
Calcio antagonisti e aritmie da riperfusione miocardica 129
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 95
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 92
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 87
[Study of preganglionic sympathetic single fibers in relation to various physiologic and pathologic stimuli]. 83
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 83
[Activity of preganglionic sympathetic single fibers during experimental coronary occlusion]. 82
[Sympathetic reflex induced by experimental coronary occlusion]. 82
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 81
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 77
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 77
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 77
FGF12 is a candidate Brugada syndrome locus. 76
Mortalità infantile e morte improvvisa in culla in Lombardia 75
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 75
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 74
The ICD for the long QT syndrome: which indications, complications, and results? 74
[A new experimental model for the study of arrhythmias dependent on the interaction between myocardial ischemia and sympathetic hyperactivity. I. Effects of phosphocreatinine]. 74
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 73
Alpha 1-adrenergic blockade and sudden cardiac death. 73
Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. 73
[Activity of afferent cardiac vagal fibers during experimental myocardial ischemia]. 71
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 70
Risk stratification in the Long-QT Syndrome 70
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 70
Legal implications of medical guidelines. A task Force of the European Society of Cardiology 69
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 69
Farmaci antipsicotici, QT lungo, morte improvvisa e rischio cardiovascolare. Il cardiologo incontra lo psichiatra 69
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (ranolazine in atrial fibrillation following an electrical cardioversion) study 69
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction 68
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 67
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 67
Sertraline treatment of major depression in patients with acute MI or unstable angina. 67
QT prolongation, sudden death, and sympathetic imbalance: the pendulum swings. 66
Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. 66
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease 66
THE SUDDEN INFANT DEATH SYNDROME: CARDIO-RESPIRATORY MECHANISMS AND INTERVENTIONS. 66
QT prolongation and sudden infant death syndrome - from theory to evidence. 66
A sympathetic reflex elicited by experimental coronary occlusion. 66
All LQT3 patients need an ICD. True or false? 65
The long QT syndrome. Prospective longitudinal study of 328 families. 65
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. 65
Task Force Report: The legal implications of medical guidelines - a Task Force of the European Society of Cardiology 64
Cost effectiveness of neonatal ECG screening for the long QT syndrome: reply. 64
Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. 64
Cardiac sodium channel dysfunction in sudden infant death syndrome. 64
Adrenergic Arrhythmogenesis and The Long QT syndrome 64
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 64
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 63
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 63
K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity. 63
on Behalf of the Azimilide Trials Investigators: Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database 62
Inherited cardiac arrhythmia syndrome. Role of potassium channels 62
An experimental approach to the choice of antiarrhythmic therapy. 62
25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. 62
[Infant mortality and sudden crib death in Lombardy]. 62
Multiple mechanisms of Na+ channel--linked long-QT syndrome. 62
Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. 62
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes 61
Nuovi rischi medico-legali per il cardiologo: la cardiologia molecolare ed il caso della sindrome del QT lungo. 61
QT lungo, sindrome del 61
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 61
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)]. 61
Cardiac potassium channel dysfunction in sudden infant death syndrome. 61
Prevalence of the congenital long-QT syndrome. 61
[Changes of a reflex nature in the cardiac sympathetic activity induced with increases of arterial pressure in spinal animals]. 61
Significance of Qt dispersion in the long QT syndrome 60
Significant left ventricular reverse remodelling following radiofrequency ablation of monomorphic ventricular ectopy in pts with idiopathic cardiomyopathy 60
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 60
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 60
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 60
Gene symbol: SCN5A 59
The quest for the mechanism of the sudden infant death syndrome. Doubts and progress 59
The RecordAF Study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation 59
Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. 59
Progress in the evaluation of a new class I antiarrhythmic agent: Penticainide 59
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? 59
Can a message from the dead save lives? 59
Chronic vagus nerve stimulation (CVNS) – A new target for treatment of congestive heart failure. 59
Two-to-one AV block associated with the congenital QT syndrome 58
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 58
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. 58
Vagal stimulation for heart failure 58
Genetic testing for the long QT syndrome: who and why? Insights for clinical management. 58
Autonomic nervous system: emerging concepts and clinical applications. 57
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 57
Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease. 57
Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. 57
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias 57
Unilateral stellectomy and dysrhythmias. 57
The long QT syndrome: a clinical counterpart of hERG mutations. 57
Cardiac arrhythmias in infancy: prevalence, significance and need for treatment. 57
QTc behavior during exercise and genetic testing for the long-QT syndrome. 57
Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. 57
[Cardio-cardiac sympathico-vagal reflex]. 57
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 57
Low penetrance in the long-QT syndrome: clinical impact. 57
Ion channel diseases in children: manifestations and management. 57
Totale 6.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019104 0 0 0 0 0 0 0 0 0 23 18 63
2019/20208.063 2.379 3.502 9 387 8 432 28 451 13 553 262 39
2020/20213.657 437 345 108 376 36 486 11 569 117 560 503 109
2021/20222.401 31 10 72 28 34 176 30 129 173 67 390 1.261
2022/20237.639 921 455 58 608 836 888 6 456 3.103 34 170 104
2023/20242.230 259 528 108 197 280 647 52 128 7 24 0 0
Totale 27.848